Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

SER-287

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

SER-287 is classified as a spore-based microbiome therapeutic composed of Firmicutes bacterial spores. It is administered orally and is designed to modulate the gut microbiota, especially for conditions like ulcerative colitisis. It is developed by Seres Therapeutics Inc.
Garber 2020 Nat. Rev. Drug Discov. 19: 655–656

…

References (Sources)

First microbiome-based drug clears phase III, in clinical trial turnaround
Garber 2020 Nat. Rev. Drug Discov. 19: 655–656

AI Chat

7/2/2026

Chat with our artificial intelligence:

Start chat!

SER-287

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat